Disclosure of the July monthly exercise status of the 35th stock acquisition rights allocated to Growth Capital. The number of issued shares is 5,936,500 shares; stock acquisition rights exercised in July total 59,365 units (40.16% of issued shares), with 7,939,500 shares remaining unexercised at month-end (79,395 units).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4586","jir_company_name":"Medrexs Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-08-03","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/08\/4586-20260803-01.pdf","jir_short_summary":"Disclosure of the July monthly exercise status of the 35th stock acquisition rights allocated to Growth Capital. The number of issued shares is 5,936,500 shares; stock acquisition rights exercised in July total 59,365 units (40.16% of issued shares), with 7,939,500 shares remaining unexercised at month-end (79,395 units).","jir_summary":"### Section heading\nThis report details the monthly exercise status for the 35th stock acquisition rights issued through a third-party allotment for July 2026. The number of issued shares is 5,936,500; rights exercised in July amount to 59,365, with an exercise ratio of 40.16% of the issued shares. At month-end, unexercised rights stood at 79,395 units (7,939,500 shares), and compliance with the exchange rules on exercise restrictions is shown.\n\n### Section 2 heading\nThe report lists the breakdown of exercise status by date, detailing the number of issued shares and the number of exercised stock acquisition rights for each exercise date from July 1 to July 31. For compliance with exercise restrictions (Listing Rule 434), the total issued shares, listed shares, and the exercise ratio are provided, with the overall exercise ratio stated as 10.00%.","jir_financial_highlights":"Number of issued shares for the target month: 5,936,500 shares (Unknown)\nNumber of stock acquisition rights exercised during the target month: 59,365 units (Unknown)\nExercise ratio to total issued shares: 40.16\uff05 (Unknown)\nUnexercised stock acquisition rights at month-end: 79,395 units (7,939,500 shares) (Unknown)","jir_category":"","jir_hashtags":"#Medrexs, #stock_option, #JapaneseStocks","jir_key_figures":"Issuing of shares: 5,936,500 shares\nNumber of stock acquisition rights exercised: 59,365 units\nExercise ratio to total issued shares: 40.16%\nUnexercised stock acquisition rights at month-end (July): 79,395 units (7,939,500 shares)","jir_meta_title":"\u3010Medrexs\u3011Notice of July Monthly Exercise Status for Stock Acquisition Rights | August 2026","jir_meta_description":"July monthly exercise status for the 35th stock acquisition rights. Issued shares: 5,936,500; exercised: 59,365 units (40.16%); unexercised: 79,395 units (7,939,500 shares). Refer to IR materials for details.","jir_og_title":"\u3010Medrexs\u3011Notice of July Monthly Exercise Status for Stock Acquisition Rights","jir_og_description":"Disclosure of July exercise status for the 35th stock acquisition rights. Issued shares: 5,936,500; exercised: 59,365; unexercised: 79,395.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59495,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-92444","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n